Clostridium Vaccine Market - Global Industry Analysis, Size, Trends, Growth, Trends, and Forecast 2018 - 2028
Gram Positive Bacterium, Clostridium Difficile, is cause for concern, particularly because infections related to this are a cause for hospital acquired infectious diarrhoea. And, the fact is widely recognized. And, this requires developing a prevention vaccine for the disease, to counter the anaerobic toxin which transfers through fecal oral route.
The global clostridium vaccine market would thus note a steady growth over the forecast period of 2018 - 2028. The robust CAGR (Compound Annual Rate Growth) will chart an upward growth curve and create lucrative growth opportunities in the global clostridium market. In, turn, this will lead to improvement in market worth.
The global clostridium vaccine market is set to witness growth and a number of notable developments are paving the way for the same. The competitive landscape is also duly impacted by these developments. A deep dive can be had in an upcoming report by Transparency Market Research.
2017: Pfizer led phase II trial of clostridium difficile vaccine – PF 06425090 – to ensure safety, efficacy, tolerability and immunogenicity in adults considered healthy, falling in the age group of 65 to 85. The phase III happened in 2017 in which a large number of 16000 participants joined.
2016: Valneva SE completed phase II for VLA84, a prophylactic vaccine developed to prevent infections of C. Difficile.
This shows how players are focused at improving Research and Development), leading the way forward. This is particularly significant for nations as of now there are not any alternative therapies available, except the antibiotics. In serious cases, it might be surgery called fecal microbiota transplant.
The global clostridium vaccine market is highly consolidated. And, key players in the global clostridium market are Valneva SE and Pfizer, Inc. Other players include Sanofi-Aventis, Merck & Co., Eli Lilly and Company, and Boehringer Ingelheim.
The global clostridium vaccine market is being driven on to a high growth trajectory, owing to a number of trends and drivers. Some of the focal ones are spelled out below.
North America is set to dominate the market landscape owing to a high prevalence of clostridium infections. Besides, there is also a high level of awareness regarding the sane. This makes more and more people seek for preventive measures, promising high growth to the market.
The study presents reliable qualitative and quantitative insights into:
The regional analysis covers:
The vast market research data included in the study is the result of extensive primary and secondary research activities. Surveys, personal interviews, and inputs from industry experts form the crux of primary research activities and data collected from trade journals, industry databases, and reputable paid sources form the basis of secondary research. The report also includes a detailed qualitative and quantitative analysis of the market, with the help of information collected from market participants operating across key sectors of the market value chain. A separate analysis of macro- and micro-economic aspects, regulations, and trends influencing the overall development of the market is also included in the report.
Highlights of the report:
Note: Immense care has been taken to present data with the highest levels of accuracy in all TMRResearch reports. Nevertheless, recent developments related to market/vendor landscape may take time to reflect in the analysis.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report